Antimicrobials in the treatment of acute otitis media. A second clinical trial.
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000367:Age Factors; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003299:Cooperative Behavior; D004338:Drug Combinations; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010033:Otitis Media / Q000188:drug therapy*; D010404:Penicillin V / Q000008:administration & dosage / Q000627:therapeutic use*; D012737:Sex Factors; D013444:Sulfisoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D004338:Drug Combinations; D004917:Erythromycin; D013444:Sulfisoxazole; D000667:Ampicillin; D010404:Penicillin V